Swaminathan, Akshay http://orcid.org/0000-0003-3426-9289
López, Iván
Mar, Rafael Antonio Garcia
Heist, Tyler
McClintock, Tom
Caoili, Kaitlin
Grace, Madeline http://orcid.org/0009-0007-8063-7253
Rubashkin, Matthew
Boggs, Michael N.
Chen, Jonathan H. http://orcid.org/0000-0002-4387-8740
Gevaert, Olivier http://orcid.org/0000-0002-9965-5466
Mou, David
Nock, Matthew K.
Article History
Received: 7 June 2023
Accepted: 24 October 2023
First Online: 21 November 2023
Competing interests
: The following authors report receiving a salary and owning equity in Cerebral Inc.: A.S., T.H., T.M., M.G., M.R., M.B., D.M. The following authors report part-time employment at Cerebral Inc. during the time of the study: I.L., R.A.G.M., K.C., A.S. owns stock in Roche (RHHVF) and is a consultant to Conduce Health. M.K.N. receives publication royalties from Macmillan, Pearson, and UpToDate. He has been a paid consultant in the past three years for Apple, Microsoft, and COMPASS Pathways, and for legal cases regarding a death by suicide. He has stock options in Cerebral Inc. He is an unpaid scientific advisor for Empatica, Koko, and TalkLife. J.H.C. reported receiving grants from the NIH/National Institute on Drug Abuse Clinical Trials Network (UG1DA015815–CTN-0136), Stanford Artificial Intelligence in Medicine and Imaging– Human-Centered Artificial Intelligence Partnership Grant, Doris Duke Charitable Foundation - Covid-19 Fund to Retain Clinical Scientists (20211260), Google Inc (in a research collaboration to leverage health data to predict clinical outcomes), and the American Heart Association - Strategically Focused Research Network - Diversity in Clinical Trials. J.H.C. reported receiving consulting fees from Sutton Pierce and Younker Hyde MacFarlane PLLC and being a co-founder of Reaction Explorer LLC, a company that develops and licenses organic chemistry education software using rule-based artificial intelligence technology. D.M. reports owning equity in Valera Inc. He is a consultant to Janssen Pharmaceuticals, Osmind, and COMPASS Pathway.